Dr. Akindele Majekodunmi, MBA, MD

Dr. Majekodunmi practices at Blueprint Healthcare in North Andover, Massachusetts.

Dr. Majekodunmi's NPI, 1447411764, was assigned on June 19, 2008. Dr. Majekodunmi holds Massachusetts license 246206.

Dr. Majekodunmi's primary practice is Blueprint Healthcare, at 451 Andover St, North Andover, MA 01845 in Essex County. The practice phone is (978) 983-2435.

Dr. Majekodunmi's primary practice is Blueprint Healthcare in North Andover, Massachusetts. Dr. Majekodunmi is also affiliated with The Miriam Hospital. The medical group on file is Blueprint Healthcare Medical Group. Dmand AI also links Dr. Majekodunmi to 4 more hospitals, 5 hospices, 5 skilled nursing facilities, 2 group practices and clinics, 2 home health agencies, 2 medical groups and 1 physician office, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Majekodunmi practices, 20 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Majekodunmi's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Majekodunmi is licensed in Massachusetts.

CMS data shows 6,986 Medicare services from Dr. Majekodunmi across 12 procedure codes in 2024, for 1,036 Medicare patients. Medicare paid $461,301 for them.

CMS counts 1,036 Medicare patients who saw Dr. Majekodunmi in 2024. The largest group is 85 and over, with 448 patients. 75% of them have high blood pressure, and 74% have high cholesterol. 46% are also on Medicaid. Their average risk score is 2.08, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Majekodunmi's median patient age at 77, with 55% women.

In 2024, Dr. Majekodunmi wrote 61,125 Medicare Part D claims for 2,147 patients. 80% of them were for generic drugs. CMS names the drug for 60,065 of them, across 362 drugs with 11 or more claims each, at $4,500,990 in total drug cost. In 2023, CMS named 55,452 claims across 349 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 21 out of 100 for Dr. Majekodunmi for performance year 2024, reported individually. Dr. Majekodunmi accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 5 general payments to Dr. Majekodunmi from 5 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 100% of the total. ACADIA Pharmaceuticals Inc paid the most, $74.